- Home
- INO vs RCMT Comparison
INO vs RCMT Comparison
Compare INO & RCMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INO | RCMT |
|---|---|---|
| Founded | 1979 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.9M | 135.6M |
| IPO Year | 1999 | 1997 |
Fundamental Metrics
Financial Performance| Metric | INO | RCMT |
|---|---|---|
| Price | $1.75 | $19.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $9.00 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 844.7K | 40.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 35.14 | N/A |
| EPS | N/A | ★ 1.34 |
| Revenue | $42,220,086.00 | ★ $186,737,000.00 |
| Revenue This Year | N/A | $16.29 |
| Revenue Next Year | $23,060.18 | $6.92 |
| P/E Ratio | ★ N/A | $14.89 |
| Revenue Growth | ★ 19.37 | 5.83 |
| 52 Week Low | $1.30 | $13.20 |
| 52 Week High | $2.86 | $28.19 |
Technical Indicators
Market Signals| Indicator | INO | RCMT |
|---|---|---|
| Relative Strength Index (RSI) | 52.38 | 54.87 |
| Support Level | $1.72 | $19.35 |
| Resistance Level | $1.78 | $21.12 |
| Average True Range (ATR) | 0.10 | 0.69 |
| MACD | -0.00 | 0.21 |
| Stochastic Oscillator | 40.13 | 67.19 |
Price Performance
Historical ComparisonAbout INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About RCMT RCM Technologies Inc.
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.